CPF Texas’s Avanos Medical AVNS Stock Holding History

CPF Texas’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$36K	Sell	525 -60	-10%	-$3.86K	0.02%	196
2018 Q2	$33K	Hold	585	–	–	0.02%	196
2018 Q1	$27K	Sell	585 -6	-1%	-$285	0.01%	196
2017 Q4	$27K	Buy	+591	New	+$27.2K	0.01%	206

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CPF Texas's AVNS Position: Q3 2018 in Review

CPF Texas reduced its Avanos Medical (AVNS) stake by 10% in Q3 2018, selling an estimated $3.86K and leaving 525 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #196.

CPF Texas first reported a position in AVNS in Q4 2017 and has held it in 4 quarters since. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

CPF Texas held 525 shares of Avanos Medical worth $36K as of Q3 2018.
CPF Texas sold 60 Avanos Medical shares in Q3 2018, an estimated $3.86K.
Avanos Medical made up 0.02% of CPF Texas's portfolio in Q3 2018, its #196 holding.
CPF Texas first reported a position in Avanos Medical in Q4 2017 and has held it in 4 quarters since.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.